Solving Kids’ Cancer is not just our name, it’s our mission. We focus on aggressive childhood cancers with low survival rates—because Every Kid Deserves to Grow Up. Solving Kids' Cancer helps accelerate new, next-generation treatments, including immunotherapy, cancer vaccines, and new drugs by applying an understanding of the entire childhood cancer research landscape to wisely invest in innovative projects.
We extend our reach globally to fully understand the research landscape so that we may influence and strengthen the science, resulting in more cures for children. Solving Kids' Cancer fosters the development of innovative clinical trials that bring more effective treatments to children both in the U.S., Europe and beyond.
The inspiration for John London in co-founding Solving Kids' Cancer belongs solely to his daughter, Penelope, who once told him "I want no one to feel yucky, Daddy." Those words drove both John and his wife, Catherine, to make sure that no other families suffer the loss his family had to endure with the passing of Penelope. As Chairman of the Board of Directors, John has primary responsibilities with SKC that include leadership and overall management of organizational governance, compliance, donor cultivation, and fundraising. John also serves as a strategic advisor in all areas of therapeutic development. He has an MBA from The Wharton School of Business, University of Pennsylvania and a Bachelor of Arts from Brown University.
Scott co-founded SKC in 2007 as a tribute to his son, Hazen Kennedy, who was diagnosed with neuroblastoma at age three. Hazen was Scott's inspiration for creating Solving Kids' Cancer in part because Hazen wanted to become a scientist when he grew up in order to help people by creating new medicines. As Executive Director, Scott is integrally involved in the identification, funding, and management of the organization's scientific programs. Before co-founding SKC, Scott worked in marketing at CDW in Chicago and then at Pfizer in New York City. He also founded a New York City theatre and sightseeing business called Manfreakinhattan. Scott has a Bachelor of Science in Chemistry and Psychology from Indiana University and a MBA from the Asian Institute of Management
Meet the Team
Scott Kennedy co-founded Solving Kids’ Cancer as a tribute to his son Hazen, who was diagnosed with neuroblastoma at age 3. As Executive Director, Scott is integrally involved in the identification, funding, and management of the organization's scientific programs. He has a BS in Chemistry and Psychology from Indiana University and an MBA from the Asian Institute of Management.
Director of Research Advocacy
Admiration for the SKC mission and method noted while her son Erik battled neuroblastoma led to a productive collaboration after his death in 2010. Donna is a voracious consumer of pediatric oncology research literature and attends major oncology meetings and presents at conferences. She is an FDA Patient Representative and on the NCI Central Review Board for COG clinical trials. In frequent contact with researchers and families globally, she stays abreast of the global patient and research landscape. She assists in identifying, analyzing, cultivating, and reviewing exciting therapeutic leads with the hope of quickly bringing the most promising therapies to the clinic. Donna has a BS in Chemical Engineering.
Director of Operations
Kristi came to Solving Kids' Cancer in 2011. She brings 25 years of not-for-profit administrative experience in management, operations, development, event planning, and marketing. Prior to SKC, Kristi managed the visual and performing arts center at Le Moyne College in Syracuse, NY.
Scientific Advisory Board
Hearn Jay Cho, MD, PhD
Mount Sinai School of Medicine
Christopher DeRenzo, MD
St. Jude's Children's Research Hospital
Andras Heczey, MD
Baylor College of Medicine
Mark Kieran, MD, PhD
Day One Biopharmaceuticals
Rimas J. Orentas, PhD
Seattle Children's Research Institute
Stephen S. Roberts, MD
Oregon Health & Science University